Intrapartum Management for Prevention of Mother-To-Child Transmission of HIV in Resource-Limited Settings: A Review of the Literature

K. Cherry Liu, Carla J. Chibwesha


Prevention of mother-to-child transmission (PMTCT) of HIV guidelines in resource-limited settings focus on antenatal and postnatal management. In this review of the literature, we present findings from select studies, highlight best practices, and present evidence-based guidelines for intrapartum PMTCT management that are applicable to resource-limited settings. We discuss the roles of intrapartum HIV testing, intrapartum antiretroviral medications, mode of delivery in settings with and without HIV RNA testing, other delivery practices, and infant care in the immediate postnatal period. With the advent of Option B+, which recommends all HIV-infected pregnant women commence lifelong combination antiretroviral therapy (ART), the potential impact for intrapartum interventions will be greatest for those women who recently have seroconverted and those with unknown HIV status. Research on intrapartum PMTCT interventions should focus on these populations. Afr J Reprod Health 2013 (Special Edition); 17[4]: 107-117).


Keywords: labor and delivery, pregnancy, PMTCT  




La prévention de la transmission du virus VIH de la mère à l'enfant (PTME)  dans les lignes directrices dans les milieux à ressources limitées met l’accent sur la gestion prénatale et postnatale. Dans cette revue de la documentation, nous présentons les résultats de certaines études, les meilleures pratiques ainsi que  les lignes directrices fondées sur des preuves pour la gestion de  la PTME de l’intrapartum qui sont applicables aux pays à ressources limitées. Nous discutons le rôle du dépistage du VIH pendant l'accouchement,  les  médicaments antirétroviraux de l’intrapartum, le mode de prestation dans des milieux avec et sans dépistage de l'ARN du VIH, d'autres pratiques d'accouchement et les soins aux nourrissons pendant la période postnatale immédiate. Avec l'avènement de l'option B +, qui recommande à toutes les femmes enceintes infectées par le VIH commencent la poly thérapie antirétrovirale continue (TAR), l'impact potentiel des interventions pendant l'accouchement sera plus grand pour les femmes qui ont récemment présenté une séroconversion et ceux dont l’état du VIH est inconnu. La recherche sur les interventions de PTME intrapartum devrait se concentrer sur ces populations. Afr J Reprod Health 2013 (Special Edition); 17[4]: 107-117).


Mots-clés: travail et accouchement,  grossesse,  PTME

Full Text:



Chi BH, Stringer JS, Moodley D. Antiretroviral Drug Regimens to Prevent Mother-To-Child Transmission of HIV: A Review of Scientific, Program, and Policy Advances for Sub-Saharan Africa. Curr HIV/AIDS Rep;10(2):124-33.

WHO. Programmatic update: Use of antiretroviral drugs for treating pregnant women and preventing HIV infection in infants. Geneva: WHO, 2012:8.

Ahmed S, Kim MH, Abrams EJ. Risks and benefits of lifelong antiretroviral treatment for pregnant and breastfeeding women: a review of the evidence for the Option B+ approach. Curr Opin HIV AIDS


Zambian Ministry of Health. Lifelong antiretroviral drugs for all HIV positive pregnanct women in Zambia - Policy guidelines for health facilities in Zambia. Lusaka: Ministry of Health, 2013.

Kongnyuy EJ, Mbu ER, Mbopi-Keou FX, Fomulu N, Nana PN, Tebeu PM, et al. Acceptability of intrapartum HIV counselling and testing in Cameroon. BMC Pregnancy Childbirth 2009;9:9.

Panel on Treatment of HIV-Infected Pregnant Women and Prevention of Perinatal Transmission.

Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-1-Infected Women for Matneral Health and Interventions to Reduce Perinatal HIV

Transmission in the United States.

Chuansumrit A, Varavithya W, Isarangkura P, Sirinavin S, Chiewsilp P, Tanprasert S, et al. Transfusiontransmitted AIDS with blood negative for anti-HIV and HIV-antigen. Vox Sang 1996;71(1):64-5.

Birkhead GS, Pulver WP, Warren BL, Hackel S, Rodriguez D, Smith L. Acquiring human immunodeficiency virus during pregnancy and mother-to-child transmission in New York: 20022006. Obstet Gynecol;115(6):1247-55.

Kim LH, Cohan DL, Sparks TN, Pilliod RA, Arinaitwe E, Caughey AB. The Cost-Effectiveness of Repeat HIV Testing During Pregnancy in a Resource-Limited Setting. J Acquir Immune Defic Syndr 2013;63(2): 195-200.

Pai NP, Tulsky JP, Cohan D, Colford JM, Jr., Reingold AL. Rapid point-of-care HIV testing in pregnant women: a systematic review and meta-analysis. Trop Med Int Health 2007;12(2):162-73.

Baisley K, Doyle AM, Changalucha J, Maganja K, Watson-Jones D, Hayes R, et al. Uptake of voluntary counselling and testing among young people participating in an HIV prevention trial: comparison of opt-out and opt-in strategies. PLoS One;7(7): e42108.

Nyuzaghl J, Ohene S, Odoi-Agyarko K. Acceptability of routine offer of HIV Testing (opt-out approach) among pregnant women in the Wa municipality. Ghana Med J;45(1):10-5.

WHO/UNAIDS. Guidance on provider-initiated HIV testing and counselling in health facilities. Geneva: WHO, 2007.

Wettstein C, Mugglin C, Egger M, Blaser N, Vizcaya LS, Estill J, et al. Missed opportunities to prevent motherto-child-transmission: systematic review and metaanalysis. AIDS 2012;26(18):2361-73.

Mwembo-Tambwe AN, Kalenga MK, Donnen P,

Humblet P, Chenge M, Dramaix M, et al. [HIV testing among women in delivery rooms in Lubumbashi, DR Congo: a catch-up strategy for prevention of motherto-child transmission]. Rev Epidemiol Sante Publique 2013;61(1):21-7.

Humphrey JH, Marinda E, Mutasa K, Moulton LH, Iliff PJ, Ntozini R, et al. Mother to child transmission of HIV among Zimbabwean women who seroconverted postnatally: prospective cohort study. BMJ 2010;341: c6580.

World Health Organization. PMTCT strategic vision 2010-2015: preventing mother-to-child transmission of HIV to reach the UNGASS and Millennium Development Goals. Geneva: World Health

Organization, 2010.

Kimmel SE, Lewis JD, Jaskowiak J, Kishel L, Hennessy S. Enhancement of medication recall using medication pictures and lists in telephone interviews. Pharmacoepidemiol Drug Saf 2003;12(1):1-8.

Lesselroth B, Adams S, Felder R, Dorr DA, Cauthers P, Church V, et al. Using consumer-based kiosk technology to improve and standardize medication reconciliation in a specialty care setting. Jt Comm J Qual Patient Saf 2009;35(5):264-70.

Eighteen-month follow-up of HIV-1-infected mothers and their children enrolled in the Kesho Bora study observational cohorts. J Acquir Immune Defic Syndr 2010;54(5):533-41.

World Health Organization. Use of antiretroviral drugs for treating pregnant women and preventing HIV infection in infants. HIV/AIDS Programme. Geneva, 2012.

McIntyre JA, Hopley M, Moodley D, Eklund M, Gray GE, Hall DB, et al. Efficacy of short-course AZT plus 3TC to reduce nevirapine resistance in the prevention of mother-to-child HIV transmission: a randomized clinical trial. PLoS Med 2009;6(10):e1000172.

Connor EM, Sperling RS, Gelber R, Kiselev P, Scott G, O'Sullivan MJ, et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med 1994;331(18):1173-80.

Warszawski J, Tubiana R, Le Chenadec J, Blanche S, Teglas JP, Dollfus C, et al. Mother-to-child HIV transmission despite antiretroviral therapy in the ANRS French Perinatal Cohort. AIDS 2008;22(2): 289-99.

Briand N, Warszawski J, Mandelbrot L, Dollfus C, Pannier E, Cravello L, et al. Is Intrapartum

Intravenous Zidovudine for Prevention of Mother-toChild HIV-1 Transmission Still Useful in the Combination Antiretroviral Therapy Era? Clin Infect Dis 2013;57(6):903-14.

Wong VV. Is peripartum zidovudine absolutely necessary for patients with a viral load less than 1,000 copies/ml? J Obstet Gynaecol 2011;31(8):740-2.

Burdge DR, Money DM, Forbes JC, Walmsley SL, Smaill FM, Boucher M, et al. Canadian consensus guidelines for the management of pregnancy, labour and delivery and for postpartum care in HIV-positive pregnant women and their offspring (summary of 2002 guidelines). CMAJ 2003;168(13):1671-4.

Arikan Y, Burdge DR. Human immunodeficiency virus infection in pregnancy. Can J Infect Dis 1998;9(5): 301-9.

Delicio AM, Milanez H, Amaral E, Morais SS, Lajos GJ, e Silva JL, et al. Mother-to-child transmission of human immunodeficiency virus in aten years period. Reprod Health;8:35.

Buchholz B, Beichert M, Marcus U, Grubert T, Gingelmaier A, Haberl A, et al. German-Austrian recommendations for HIV1-therapy in pregnancy and in HIV1-exposed newborn, update 2008. Eur J Med Res 2009;14(11):461-79.

Aebi-Popp K, Mulcahy F, Rudin C, Hoesli I, Gingelmaier A, Lyons F, et al. National Guidelines for the prevention of mother-to-child transmission of HIV across Europe - how do countries differ? Eur J Public Health 2013.

Lussiana C, Clemente SV, Ghelardi A, Lonardi M, Pulido Tarquino IA, Floridia M. Effectiveness of a prevention of mother-to-child HIV transmission programme in an urban hospital in Angola. PLoS One;7(4):e36381.

Mirochnick M, Rodman JH, Robbins BL, Fridland A, Gandia J, Hitti J, et al. Pharmacokinetics of oral zidovudine administered during labour: a preliminary study. HIV Med 2007;8(7):451-6.

Bhadrakom C, Simonds RJ, Mei JV, Asavapiriyanont S,

Sangtaweesin V, Vanprapar N, et al. Oral zidovudine

during labor to prevent perinatal HIV transmission, Bangkok: tolerance and zidovudine concentration in cord blood. Bangkok Collaborative Perinatal HIV Transmission Study Group. AIDS 2000;14(5):509-16.

The mode of delivery and the risk of vertical transmission of human immunodeficiency virus type 1--a metaanalysis of 15 prospective cohort studies. The International Perinatal HIV Group. N Engl J Med 1999;340(13):977-87.

Elective caesarean-section versus vaginal delivery in prevention of vertical HIV-1 transmission: a randomised clinical trial. Lancet 1999;353(9158): 1035-9.

Anderson B, Cu-Uvin S. Prenatal evaluation and intrapartum management of the HIV-infected patient in resource-rich settings. In: Mofenson L, editor, 2013.

ACOG committee opinion scheduled Cesarean delivery and the prevention of vertical transmission of HIV infection. Number 234, May 2000 (replaces number 219, August 1999). Int J Gynaecol Obstet 2001;73(3): 279-81.

Jamieson DJ, Read JS, Kourtis AP, Durant TM, Lampe MA, Dominguez KL. Cesarean delivery for HIVinfected women: recommendations and controversies. Am J Obstet Gynecol 2007;197(3 Suppl):S96-100.

Minkoff H, Burns DN, Landesman S, Youchah J, Goedert JJ, Nugent RP, et al. The relationship of the duration of ruptured membranes to vertical transmission of human immunodeficiency virus. Am J Obstet Gynecol 1995;173(2):585-9.

Mother-to-child transmission of HIV infection in the era of highly active antiretroviral therapy. Clin Infect Dis 2005;40(3):458-65.

Townsend CL, Cortina-Borja M, Peckham CS, de Ruiter A, Lyall H, Tookey PA. Low rates of mother-to-child transmission of HIV following effective pregnancy interventions in the United Kingdom and Ireland, 2000-2006. AIDS 2008;22(8):973-81.

Forbes JC, Alimenti AM, Singer J, Brophy JC, Bitnun A, Samson LM, et al. A national review of vertical HIV transmission. AIDS;26(6):757-63.

Cotter AM, Brookfield KF, Duthely LM, Gonzalez Quintero VH, Potter JE, O'Sullivan MJ. Duration of membrane rupture and risk of perinatal transmission of HIV-1 in the era of combination antiretroviral therapy. Am J Obstet Gynecol;207(6):482 e1-5.

Mark S, Murphy KE, Read S, Bitnun A, Yudin MH. HIV mother-to-child transmission, mode of delivery, and duration of rupture of membranes: experience in the current era. Infect Dis Obstet Gynecol;2012:267969.

Chibwesha CJ, Giganti MJ, Putta N, Chintu N, Mulindwa J, Dorton BJ, et al. Optimal time on HAART for prevention of mother-to-child transmission of HIV. J Acquir Immune Defic Syndr 2011;58(2):224-8.

Alvarez JR, Bardeguez A, Iffy L, Apuzzio JJ. Preterm premature rupture of membranes in pregnancies complicated by human immunodeficiency virus infection: a single center's five-year experience. J Matern Fetal Neonatal Med 2007;20(12):853-7.

Cu-Uvin S, DeLong AK, Venkatesh KK, Hogan JW, Ingersoll J, Kurpewski J, et al. Genital tract HIV-1 RNA shedding among women with below detectable plasma viral load. AIDS;24(16):2489-97.

Sebitloane HM, Moodley J, Esterhuizen TM.

Determinants of postpartum infectious complications among HIV uninfected and antiretroviral naive-HIV infected women following vaginal delivery: a prospective cohort study. Eur J Obstet Gynecol Reprod Biol 2009;145(2):158-62.

Risk factors for mother-to-child transmission of HIV-1. Lancet 1992;339(8800):1007-12.

Aagaard-Tillery KM, Lin MG, Lupo V, Buchbinder A, Ramsey PS. Preterm premature rupture of membranes in human immunodeficiency virus-infected women: a novel case series. Infect Dis Obstet Gynecol 2006; 2006:53234.

Homsy J, Moore D, Barasa A, Were W, Likicho C, Waiswa B, et al. Breastfeeding, mother-to-child HIV transmission, and mortality among infants born to HIV-Infected women on highly active antiretroviral therapy in rural Uganda. J Acquir Immune Defic Syndr 2010;53(1):28-35.

Cournil A, De Vincenzi I, Gaillard P, Cames C, Fao P, Luchters S, et al. Relationship between mortality and feeding modality among children born to HIVinfected mothers in a research setting: The Kesho Bora Study. AIDS 2012.

Vogler MA, Singh H, Wright R. Complex decisions in managing HIV infection during pregnancy. Curr HIV/AIDS Rep;8(2):122-31.

Lallemant M, Jourdain G, Le Coeur S, Kim S, Koetsawang S, Comeau AM, et al. A trial of shortened zidovudine regimens to prevent mother-tochild transmission of human immunodeficiency virus type 1. Perinatal HIV Prevention Trial (Thailand) Investigators. N Engl J Med 2000;343(14):982-91.

Kumwenda NI, Hoover DR, Mofenson LM, Thigpen MC, Kafulafula G, Li Q, et al. Extended antiretroviral prophylaxis to reduce breast-milk HIV-1 transmission. N Engl J Med 2008;359(2):119-29.

Bedri A, Gudetta B, Isehak A, Kumbi S, Lulseged S, Mengistu Y, et al. Extended-dose nevirapine to 6 weeks of age for infants to prevent HIV transmission via breastfeeding in Ethiopia, India, and Uganda: an analysis of three randomised controlled trials. Lancet 2008;372(9635):300-13.

Kilewo C, Karlsson K, Massawe A, Lyamuya E, Swai A, Mhalu F, et al. Prevention of mother-to-child transmission of HIV-1 through breast-feeding by treating infants prophylactically with lamivudine in Dar es Salaam, Tanzania: the Mitra Study. J Acquir Immune Defic Syndr 2008;48(3):315-23.

Chasela CS, Hudgens MG, Jamieson DJ, Kayira D, Hosseinipour MC, Kourtis AP, et al. Maternal or infant antiretroviral drugs to reduce HIV-1 transmission. N Engl J Med 2010;362(24):2271-81.

Giles M. HIV and pregnancy: screening and management update. Curr Opin Obstet Gynecol 2009;21(2):131-5.


  • There are currently no refbacks.